Establishment of the Lynx Dx Cancer Research Biobank for Advancing Clinical Studies on Urinary Biomarkers

Overview

About this study

The purpose of this study is to establish a repository of well-documented and properly preserved biospecimens for use in research regarding urinary biomarker tests for the workup of PCa.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Male
Age ≥ 18 years
Undergoing prostate biopsy for detection or monitoring of cancer

Exclusion Criteria:

Prior treatment for prostate cancer

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 08/16/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Ram Pathak, M.D.	Contact us for the latest status	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Ram Pathak, M.D.

Contact us for the latest status

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Clinical Trials